NHSX Adoption Fund awarded projects to improve digital pathways in England

15

Nov 2021

In November 2021, NHSX announced projects to improve digital pathways awarded for funding from the newly created Adoption Fund. The Adoption Fund will support innovations that have some evidence base in the NHS and can address elective recovery, are compliant with DTAC (Digital Technology Assessment Criteria), are not being funded elsewhere by the NHS, and have the potential for rapid, wide rollout across the NHS. Funding opportunities will support Integrated Care Systems (ICSs) with initiatives to test out digital pathways across various specialty areas:

  • Gastroenterology pathways with up to £200,000 funding available per ICS;
  • Musculoskeletal pathways with up to £200,000 funding available per ICS;
  • Cardiology and cardiac surgery networks with up to £750,000 funding available per cardiac network;
  • Perioperative pathways with up to £500,000 funding available per ICS;
  • Initiatives to support digital inclusion with up to £20,000 per ICS.

The applications were submitted by ICSs to NHSX in August - September 2021. A total of 35 applications were successful and will share funding of £6.5 million.

Eight applications were awarded in the gastroenterology pathway, including the following:

  • IBDoc: Gastro remote care & monitoring. A pilot project for home monitoring of inflammatory bowel disease (IBD) patients using IBDoc, a diagnostic device to determine fecal calprotectin levels in stool samples;
  • Home fecal calprotectin testing pilot in an area of high social deprivation. Pilot project with the use of home fecal calprotectin, in conjunction with DrDoctor tool, within three different groups of IBD patients;
  • Automated endoscopy bowel prep pre-assessment and patient education (Remcare app);
  • Integrating e-Health into the IBD patient pathway using virtual monitoring and fecal calprotectin home testing; Patients will be offered a virtual review via the My IBD Care app, with three monthly calprotectin testing using the CalproSmart home test kits. A smaller group will also trial the feasibility of the Thriva at-home blood testing;
  • Supported self-management and remote monitoring of IBD patients within Herefordshire and Worcestershire. A project to implement the use of the My IBD Care app alongside the CalproSmart at-home fecal calprotectin;

Nine applications were awarded in the musculoskeletal pathway, including the following:

  • Empowering self-management through online education for MSK conditions (Harrogate Health Hub);
  • Web-based exercise prescription to support self-management (Physitrack);
  • Using decision support tools to self-manage low back pain (SelfBack and STarTBack platforms);
  • Going paperless to support patients to self-manage MSK conditions (MyRecovery);
  • Video-based exercise rehabilitation and physiotherapy-led group exercise classes (Rehab Me app);
  • Integrating voluntary, community, and prescribing social resources into digital self-management for common musculoskeletal conditions (GetUBetter platform).

Two applications were awarded in the cardiology and cardiac surgery area:

  • London Cardiac Networks seeks funding for remote monitoring technology and change management resources to implement remote monitoring pathways in elective cardiac surgery and cardiac lists (TAVI, PCI, ablation) in eight London sites. Procured digital solutions will enhance pre and postoperative pathways through digital investigation and virtual clinical tools;
  • Cheshire and Merseyside Cardiac Network has a long track record in delivering enhanced clinical pathways through scaled-up adoption of telehealth. The intention is to expand the use of Docobo, a digital platform already identified by the ICS with a telehealth hub and infrastructure already in place. Docobo’s effectiveness as a telehealth solution has already been established; hence the pilot can focus on the benefits its use brings to the pathway.

Six applications were awarded in the perioperative pathway, and ten projects were awarded as Digital Health Inequality Pioneers (DiHiP).

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more